Why Walgreens Is Reportedly Considering a Private Equity Buyer
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.
In a webinar sponsored by Personify Health, executives from international chemical company Dow and the National Alliance of Healthcare Purchaser Coalitions discussed some of the tough choices companies are making.
Senators Elizabeth Warren and Josh Hawley and Representatives Diana Harshbarger and Jake Auchincloss introduced the Patients Before Monopolies Act on Wednesday. It aims to prohibit the parent company of a PBM or insurer from owning a pharmacy business.
Dr. Shantanu Nundy describes how care navigation company Accolade can help self-insured employers lower costs for providing health coverage to their employees.
In a letter, Families USA and numerous other organizations called on Congress to extend the enhanced premium tax credits that are set to expire at the end of 2025.
A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges.
After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of anticompetitive rebating practices related to insulin, the defendants reversed roles and became plaintiffs. In November, they countersued the agency, arguing that its lawsuit is unconstitutional.
Hinge Health is the first musculoskeletal care provider to be added to Amazon’s Health Condition Programs.
By increasing the availability of services through flexible payment methods, providers have an opportunity to expand their customer base and establish themselves as trusted partners in the wellness journey.
StretchDollar's $6 million raise was led by Fika Ventures and Oscar Health and included participation from Precursor Ventures and Springbank.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Fello's $10.4 million raise includes a seed investment from Glen Tullman’s 62Ventures, The Capital Factory Fellowship Fund, Katalyst Capital and Offline Ventures.
It comes down to two simple questions that every health plan should consider: “Are we a company that pays for services and manages risks? Or are we a company that delivers better health for our members?”
Merative, a data, analytics and technology provider, is Morgan Health's eighth portfolio company. The investment will help accelerate growth.
Global medical costs are expected to rise by double digits for the third year in a row, according to a recent survey from WTW.
Several healthcare leaders are supporting the Biden-Harris administration’s proposed rule to expand Medicare and Medicaid coverage of GLP-1 medications for obesity treatment.